This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $1200

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Mabrouka Maamra
Project Manager at University of Sheffield
Speaker

Profile

As a PhD student and postdoctoral scientist, I focused on developing therapeutics for endocrine and kidney diseases, employing a diverse range of molecular, cellular, and animal models. My work included the design, production, screening and validation of mutant cytokines and antibodies.

In 2023, I transitioned to a project management role with Dr. Zoltan Kis at the University of Sheffield, contributing to research initially funded by the Wellcome Leap R3 program. Our current efforts address the critical challenge of rapid, large-scale vaccine production for pandemic response. We aim to enable high-quality, cost-effective manufacturing through the development and modeling of rapid-response vaccine production platform technologies.

Agenda Sessions

  • Addressing Manufacturing Challenges: Intensified, Continuous and Digitalised Production of High-quality mRNA Medicines at Low Cost

    9:00am